Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
AssigneeBiogaia AB
InventorsEamonn Connolly, Bo Mollstam
Life of this patent
Estimating the term…
Abstract
Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
Claims1
A method for selecting a lactic acid bacterial strain for administration to a mammal for reducing gastrointestinal inflammation associated with Helicobacter pylori infection in the gastrointestinal tract of said mammal, comprising the steps of:
- a) selecting and culturing a Lactobacillus strain;
- b) obtaining a cell-free culture supernatant from said strain;
- and
- c) evaluating the level of TNFα in the supernatant using a model system.
Dependencies are inferred from the claim text.